LTFS
SYRS

Ladenburg Thalmann Financial Services’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$6K Buy
90
+25
+38% +$1.52K ﹤0.01% 4729
2019
Q3 		$7K Hold
65
– – ﹤0.01% 4560
2019
Q2 		$6K Hold
65
– – ﹤0.01% 4663
2019
Q1 		$6K Hold
65
– – ﹤0.01% 4602
2018
Q4 		$4K Sell
65
-50
-43% -$3.8K ﹤0.01% 4702
2018
Q3 		$14K Hold
115
– – ﹤0.01% 4120
2018
Q2 		$14K Hold
115
– – ﹤0.01% 4066
2018
Q1 		$14K Buy
+115
New +$12.6K ﹤0.01% 4066
2017
Q4 		– Sell
-50
Closed -$7K – 5137
2017
Q3 		$7K Buy
+50
New +$9.4K ﹤0.01% 4270

Other funds holding SYRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ladenburg Thalmann Financial Services's SYRS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Syros Pharmaceuticals, Inc. Common Stock (SYRS) stake by 38% in Q4 2019, buying an estimated $1.52K and bringing the position to 90 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4729.

Ladenburg Thalmann Financial Services first reported a position in SYRS in Q3 2017 and has held it in 9 quarters since. The position peaked at $14K in Q3 2018. 70 funds tracked by Wall St. Rank hold SYRS as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 90 shares of Syros Pharmaceuticals, Inc. Common Stock worth $6K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 25 Syros Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $1.52K.
  • Syros Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4729 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2017 and has held it in 9 quarters since.
  • Ladenburg Thalmann Financial Services's Syros Pharmaceuticals, Inc. Common Stock position peaked at $14K in Q3 2018.
  • 70 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.